CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Poison pill unlikely to end the battle for Twitter shares

The Twitter board has rejected Elon Musk’s offer to take the social media company private, and instead implemented the highly successful poison pill defence.

Elon Musk has plenty of reasons to gain control of Twitter (NYSE: TWTR). And after spending $2.9 billion acquiring 9.3% of the social media company’s shares, it appeared as though he would take a board seat to influence its strategy.

However, the eccentric billionaire has declined the seat and is now after complete ownership of Twitter as a private company.

Twitter share price: poison pill

After turning down the seat, Musk notified the social media company he intended to purchase ‘100% of Twitter for $54.20 per share in cash, a 54% premium over the day before I began investing in Twitter and a 38% premium over the day before my investment was publicly announced.’

The Tesla founder argued that Twitter had the ‘potential to be the platform for free speech around the globe’ but that ‘the company will neither thrive nor serve this societal imperative in its current form. Twitter needs to be transformed as a private company.’

The billionaire further clarified that it was his best and final offer, emphasising he would not be ‘playing the back-and-forth game,’ and that the offer was ‘high price and your shareholders will love it.’

In response, Twitter’s board blocked the takeover offer and unanimously declared a limited-duration shareholder rights plan, aptly dubbed the poison pill strategy. This defence allows existing shareholders to buy new Twitter shares at half the market price if any shareholder were to acquire more than 15% of the company without board approval.

The strategy has been highly successful in the past and provides a strong disincentive for Musk to pursue a hostile takeover. The poison pill expires on 14 April 2023.

Musk had warned that if the board rejected his offer, he ‘would need to reconsider my position as a shareholder,’ claiming ‘this is not a threat, it’s simply not a good investment without the changes that need to be made.’

Where next for Twitter shares?

The trajectory of Twitter’s share price is now unclear. In the worst-case scenario, Musk could dump his entire shareholding onto the market. Of course, despite his declaration, he could also issue an improved offer.

But CEO Parag Agrawal believes the company is not being ‘held hostage’ by Musk’s offer, and that ‘we as employees control what happens.’

And Twitter has emphasised that its poison pill ‘does not prevent the Board from engaging with parties or accepting an acquisition proposal if the Board believes that it is in the best interests of Twitter and its shareholders.’

A bidding war could erupt. Thoma Bravo LP has contacted Twitter to express interest in a competing offer, while Vanguard has increased its shareholding to 10.3%, surpassing Musk’s 9.3%.

And Musk is now talking to potential takeover partners, including private equity firm Silver Lake. Silver Lake co-CEO Egon Durban is a Twitter board member and reportedly led Musk’s failed attempt to take Tesla private in 2018.

And Twitter’s board collectively only owns 0.12% of Twitter shares. This led Musk to declare, not unreasonably, that ‘objectively, their economic interests are simply not aligned with shareholders.’ CEO Agrawal only owns 0.063%.

Musk believes that refusing the deal is tantamount to ‘breaching their fiduciary duty,’ and moreover that the board would assume liability ‘titanic in scale.’ And by rejecting such a high premium, Twitter’s board is now at risk of lawsuits from shareholders. Some may even argue they prioritised their own roles with Musk declaring ‘I don’t have confidence in management.’

However, Twitter’s share price was $77.06 in February 2021, and the board could well argue the offer does not reflect Twitter’s growth prospects. Of course, Musk could also make a direct tender offer to shareholders, eliminating the need for board approval.

But another possibility comes from Twitter co-founder and former CEO Jack Dorsey. Quitting the board next month, he’s argued it’s ‘consistently the dysfunction of the company.’

Dorsey is now better known as the founder and CEO of Block. The payments company incorporates Square as well as Bitcoin-focussed Spiral and decentralised finance project TBD.

Intriguingly, he joined the board of Twitter-funded social media project Bluesky in February, three months after stepping down as Twitter’s CEO. The decentralised nature of the project chimes with Musk’s championing of free speech.

With so many variables, Twitter shares will remain all aflutter.

Trade over 16,000 international shares with us, Singapore’s No.1 trading provider.* Learn more about trading shares with us, or open an account to get started today.

*Awarded the Best Online Trading Platform by Influential Brands in 2021.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.


Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.